Ceftibuten CAS:97519-39-6
Ceftibuten is prescribed by healthcare providers for the treatment of acute bacterial exacerbation of chronic bronchitis, urinary tract infections, pharyngitis, tonsillitis, and uncomplicated skin and skin structure infections caused by susceptible bacteria. Patients are advised to consult with a healthcare professional to determine the appropriate dosage and duration of ceftibuten treatment based on the specific type and severity of the infection. Patients typically take ceftibuten orally as directed by their healthcare provider. It is important to complete the full course of treatment even if symptoms improve before completion to ensure the eradication of the bacterial infection and reduce the risk of recurrence. While ceftibuten is generally well-tolerated, common side effects may include gastrointestinal disturbances, allergic reactions, or headaches. Patients should be monitored for any adverse reactions during treatment, and any severe or persistent side effects should be reported to a healthcare provider promptly for evaluation and management. Overall, ceftibuten is an effective oral antibiotic used to combat bacterial infections when administered correctly under medical guidance.
Composition | C15H14N4O6S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 97519-39-6 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |